In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Biopharma Insights & Commentary

Market forecasts and insights that deliver a deeper understanding of the future global role of biopharmaceuticals — and the dynamics that shape the market.

  • An Economic Analysis of Generic Drug Usage in the United States

    GPhA Report, Sep 26, 2011

    A study conducted by the IMS Institute for Healthcare Informatics for the Generics Pharmaceutical Association (GPhA) finds that generic versions of brand name drugs helped save the American healthcare system more than $931 Bn over the past decade.

    Is the ‘Emerging Market’ a Dated Concept?

    Pharmaceutical Executive, August 2011

    Our experts share their insights about anticipating risk, staying agile, understanding culture, and dropping the HQ comfort-zone mentality to achieve commercial excellence in the pharmerging markets.

    Longing To Believe In Evidence-Based Medicine

    Biotechnology Healthcare, Winter 2010/2011

    The use of evidence-based medical research to support greater healthcare transparency.

    Advances in Adherence

    PM360, August 2010

    IMS's Jon Tierce and Michel Denarie discuss recent advances in integrating and managing data from Specialty Pharmacy Providers (SPPs). 

    Gastric Acid-Related Diseases and PPIs

    Canadian Pharmaceutical Marketing, February 2010

    Therapeutic insights and key trends by IMS on gastric-related diseases are highlighted in this article on the evolution of the Canadian PPI market.

  • Three New Analyses in World Pharmaceutical Frontiers

    World Pharmaceutical Frontiers, December 2009/January 2010

    A trio of articles written for World Pharmaceutical Frontiers delivers IMS insight around the global pharmaceutical market and demand for medicines, personalized medicine, and stem cell research.

    Emerging Potential - Industry in Figures

    World Pharmaceutical Frontiers, December 2009/January 2010

    Published in World Pharmaceutical Frontiers, IMS’s Murray Aitken discusses trends in the global pharmaceutical market and how the emerging economies hold strong potential for growth.

    Generics Makers Stand to Reap Great Rewards in China's Pharma Market

    Journal of Generic Medicines, March 2009

    This IMS published article in the Journal of Generic Medicines discusses China’s growing generic sector.